SKYE logo

Skye Bioscience, Inc. (SKYE)

Profile

Full Name

Skye Bioscience, Inc.

Ticker

NASDAQ: SKYE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 26, 2014

Indexes

Not included

Website

https://skyebioscience.com

Employees

16

Key Details

Price

$3.96(+1.28%)

Market cap

$122.71M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$0.73(+86.41% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.96
    SKYE price is $3.96

    30-Day Relative Volume

    1.09
    SKYE 30-day relative volume is 1.09

    Price Performance

    Price Today change

    +1.28%
    SKYE price is up +1.28% today

    Price YTD change

    +39.93%
    SKYE price is up +39.93% since January 1st

    Price 1-year change

    -24.43%
    SKYE price is down -24.43% year-on-year

    Price 3-year change

    -36.64%
    SKYE price is down -36.64% over the past 3 years

    Price Range

    Price All-time high

    $1937.50
    SKYE price is currently -99.80% below its historical high of $1937.50

    Price 3-year low

    $1.14
    SKYE price is currently +247.37% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $122.71M
    SKYE market capitalization is $122.71 million

    Market cap 3-year change

    +889.78%
    SKYE market capitalization is up +889.78% over the past 3 years

    Market cap All-time high

    $487.17M
    SKYE market capitalization is currently -74.81% below its historical high of $487.17 million

    Market cap sector rank

    43.71%
    SKYE market capitalization is higher than 43.71% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.14%
    SKYE shares outstanding is up +2.14% year-on-year

    Shares Outstanding 3-Year Change

    +1462.15%
    SKYE shares outstanding is up +1462.15% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.70
    SKYE beta is 1.70

    200-day SMA

    $2.88
    SKYE price is currently +37.39% above its 200-day simple moving average

    50-day SMA

    $3.72
    SKYE price is currently +6.55% above its 50-day simple moving average

    RSI

    53.92
    SKYE 14-day relative strength index is 53.92

    Volume

    1.09
    SKYE 30-day relative volume is 1.09

    ATR

    $0.32
    SKYE average true range is $0.32

    10-day Historical Volatility

    78.11%
    SKYE 10-day historical volatility is 78.11%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    SKYE annual revenue is $0.00

    Revenue Analysts estimate

    -
    SKYE annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    SKYE annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    SKYE annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$0.73
    SKYE annual earnings per share is -$0.73

    EPS Analysts estimate

    -$1.34
    SKYE annual earnings per share is currently -45.66% lower than the consensus analysts' forecast

    EPS 1-year change

    +86.41%
    SKYE annual earnings per share is up +86.41% year-on-year

    EPS Sector rank

    57.85%
    SKYE annual earnings per share is higher than 57.85% of companies in Healthcare sector

    Profit

    Gross profit

    -$298.60K
    SKYE annual gross profit is -$298.60 thousand

    Gross margin

    -
    SKYE annual gross profit margin value is unknown

    Operating profit

    -$36.43M
    SKYE annual operating income is -$36.43 million

    Operating margin

    -
    SKYE annual operating profit margin value is unknown

    Net income

    -$26.57M
    SKYE annual net profit is -$26.57 million

    Net margin

    -
    SKYE annual net profit margin value is unknown

    Expenses

    Total expenses

    $26.57M
    SKYE annual total expenses is $26.57 million

    Operating expenses

    $36.13M
    SKYE annual total operating expenses is $36.13 million

    Cost of goods sold

    $298.60K
    SKYE annual cost of goods sold is $298.60 thousand

    Selling, general & administrative expenses

    $0.00
    SKYE annual SGA is $0.00

    Depreciation and amortization

    $298.60K
    SKYE annual depreciation & amortization is $298.60 thousand

    Interest expense

    $0.00
    SKYE annual interest expense is $0.00

    Income tax

    $10.10K
    SKYE annual income tax is $10.10 thousand

    EBIT & EBITDA

    EBIT

    -$36.43M
    SKYE annual earnings before interest & taxes is -$36.43 million

    EBITDA

    -$36.13M
    SKYE annual EBITDA is -$36.13 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $72.76M
    SKYE annual total assets is $72.76 million

    Non current assets

    $1.94M
    SKYE annual long term assets is $1.94 million

    Current assets

    $70.83M
    SKYE annual total current assets is $70.83 million

    Cash and cash equivalents

    $68.42M
    SKYE annual cash & cash equivalents is $68.42 million

    Accounts receivable

    -
    SKYE annual accounts receivable value is unknown

    Inventory

    $0.00
    SKYE annual inventory is $0.00

    Liabilities

    Total liabilities

    $4.61M
    SKYE annual total liabilities is $4.61 million

    Long term liabilities

    $273.20K
    SKYE annual total long term liabilities is $273.20 thousand

    Current liabilities

    $4.34M
    SKYE annual total current liabilities is $4.34 million

    Accounts payable

    $569.30K
    SKYE annual accounts payable is $569.30 thousand

    Debt

    Total debt

    $455.60K
    SKYE annual total debt is $455.60 thousand

    Total debt 1-year change

    -90.13%
    SKYE annual total debt is down -90.13% year-on-year

    Long term debt

    $273.20K
    SKYE annual long term debt is $273.20 thousand

    Short term debt

    $182.40K
    SKYE annual short term debt is $182.40 thousand

    Equity & Capital

    Shareholders equity

    $68.15M
    SKYE annual stockholders equity is $68.15 million

    Book value

    $68.15M
    SKYE annual book value is $68.15 million

    Retained earnings

    -$130.95M
    SKYE annual retained earnings is -$130.95 million

    Working capital

    $66.49M
    SKYE annual working capital is $66.49 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$25.24M
    SKYE annual cash flow from operations is -$25.24 million

    Cash from operations 1-year change

    -80.89%
    SKYE annual cash flow from operations is down -80.89% year-on-year

    Cash from investing

    -$245.60K
    SKYE annual cash flow from investing activities is -$245.60 thousand

    Cash from investing 1-year change

    -103.72%
    SKYE annual cash flow from investing activities is down -103.72% year-on-year

    Cash from financing

    $83.56M
    SKYE annual cash flow from financing activities is $83.56 million

    Cash from financing 1-year change

    +408.18%
    SKYE annual cash flow from financing activities is up +408.18% year-on-year

    CAPEX

    CAPEX

    $1.60M
    SKYE annual capital expenditures is $1.60 million

    CAPEX 1-year change

    +12630.16%
    SKYE annual capital expenditures is up +12630.16% year-on-year

    Free Cash Flow

    Free cash flow

    -$26.84M
    SKYE annual free cash flow is -$26.84 million

    Free cash flow 1-year change

    -92.21%
    SKYE annual free cash flow is down -92.21% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    SKYE annual gross profit margin value is unknown

    Operating margin

    -
    SKYE annual operating profit margin value is unknown

    Net margin

    -
    SKYE annual net profit margin value is unknown

    ROA & ROE

    ROA

    -62.73%
    SKYE annual return on assets is -62.73%

    ROE

    -80.48%
    SKYE annual return on equity is -80.48%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SKYE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SKYE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.81
    SKYE price to book ratio is 2.81

    PB ratio Sector rank

    62.83%
    SKYE price to book ratio is higher than 62.83% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    SKYE price to sales ratio value is unknown

    PS ratio Sector rank

    -
    SKYE price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $74.50M
    SKYE enterprise value is $74.50 million

    Enterprise value Sector rank

    42.64%
    SKYE enterprise value is higher than 42.64% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.45
    SKYE EV/EBITDA is -1.45

    EV/EBITDA Sector rank

    42.15%
    SKYE EV/EBITDA is higher than 42.15% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    16.32
    SKYE annual current ratio is 16.32

    Quick ratio

    16.32
    SKYE annual quick ratio is 16.32

    Leverage

    Debt to equity

    0.01
    SKYE annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    SKYE annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    SKYE piotroski f-score value is unknown

    Altman Z-Score

    12.89
    SKYE altman z-score is 12.89

    Analyst ratings

    Recent major analysts updates

    Aug 15, 25 Evercore ISI Group
    Outperform
    Jun 24, 25 JMP Securities
    Market Outperform
    Mar 21, 25 Craig-Hallum
    Buy
    Mar 21, 25 Citizens Capital Markets
    Market Outperform
    Feb 28, 25 William Blair
    Outperform
    Sep 30, 24 Scotiabank
    Sector Outperform
    Sep 20, 24 Piper Sandler
    Overweight
    Sep 20, 24 Cantor Fitzgerald
    Overweight
    Sep 10, 24 JMP Securities
    Market Outperform
    Sep 9, 24 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with SKYE included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Skye Bioscience, Inc.?
    • Does Skye Bioscience, Inc. pay dividends?
    • What sector is Skye Bioscience, Inc. in?
    • What industry is Skye Bioscience, Inc. in?
    • What country is Skye Bioscience, Inc. based in?
    • When did Skye Bioscience, Inc. go public?
    • Is Skye Bioscience, Inc. in the S&P 500?
    • Is Skye Bioscience, Inc. in the NASDAQ 100?
    • Is Skye Bioscience, Inc. in the Dow Jones?
    • When was Skye Bioscience, Inc.'s last earnings report?
    • When does Skye Bioscience, Inc. report earnings?

    What is the ticker symbol for Skye Bioscience, Inc.?

    The ticker symbol for Skye Bioscience, Inc. is NASDAQ:SKYE

    Does Skye Bioscience, Inc. pay dividends?

    No, Skye Bioscience, Inc. does not pay dividends

    What sector is Skye Bioscience, Inc. in?

    Skye Bioscience, Inc. is in the Healthcare sector

    What industry is Skye Bioscience, Inc. in?

    Skye Bioscience, Inc. is in the Biotechnology industry

    What country is Skye Bioscience, Inc. based in?

    Skye Bioscience, Inc. is headquartered in United States

    When did Skye Bioscience, Inc. go public?

    Skye Bioscience, Inc.'s initial public offering (IPO) was on November 26, 2014

    Is Skye Bioscience, Inc. in the S&P 500?

    No, Skye Bioscience, Inc. is not included in the S&P 500 index

    Is Skye Bioscience, Inc. in the NASDAQ 100?

    No, Skye Bioscience, Inc. is not included in the NASDAQ 100 index

    Is Skye Bioscience, Inc. in the Dow Jones?

    No, Skye Bioscience, Inc. is not included in the Dow Jones index

    When was Skye Bioscience, Inc.'s last earnings report?

    Skye Bioscience, Inc.'s most recent earnings report was on August 7, 2025

    When does Skye Bioscience, Inc. report earnings?

    The date for Skye Bioscience, Inc.'s next earnings report has not been announced yet
    On this page